14th March 2025
- 0 comments
Lant Medical has secured £500,000 investment from Innovate UK, the UK's innovation agency, and two angel investors from the Northern Investor Hub to design a clinical trial for a promising new non-antibiotic treatment, designed to eradicate cancer-causing Helicobacter pylori (H. pylori).
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage